Healthtech: Europe’s 10 most-funded companies in H1 2026
In the first half of 2026, European healthtech received significant funding across ten major transactions totaling €2.59 billion. Isomorphic Labs dominated with $2.1 billion in Series B funding for its AI-powered drug discovery platform, accounting for 69% of the top-ten total. Investment spanned biotechnology, medical devices, AI-driven diagnostics, robotic blood collection and chronic disease management, with the UK leading in capital attraction.
Key points
- €2.59B raised across ten major European healthtech deals in H1 2026
- Isomorphic Labs raised $2.1B for AI drug discovery platform
- Funding supports AI diagnostics, biotech, and medical robotics
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Tech.eu did the reporting; read the original for the full story.
Read the full story at Tech.eu
